[
    {
        "type": "search_results",
        "search_results": [
            {
                "text": "Published: 2024-11-18 PMID: 39555724 (https://pubmed.ncbi.nlm.nih.gov/39555724/) %START_SNIPPET%Abstract: Leukemia is highly heterogeneous, meaning that different types of leukemia require different\ntreatments and have different prognoses.%END_SNIPPET% Current clinical diagnostic and typing tests are complex and\ntime-consuming. In particular, all of these tests rely on bone marrow aspiration, which is invasive and leads\nto poor patient compliance, exacerbating treatment delays.",
                "score": 0.7401612401008606,
                "part_metadata": {
                    "page": 9,
                    "lang": "eng",
                    "section": 44,
                    "offset": 0,
                    "len": 143
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Published: 2024-- PMID: 39555174 (https://pubmed.ncbi.nlm.nih.gov/39555174/) %START_SNIPPET%Abstract: 5'-Noraristeromycin as a racemic mixture of enantiomers was found to exhibit a pronounced\ncytotoxic effect on leukemia cells; IC for the Jurkat, K562, and THP-1 cell lines was 7.3, 1.3, and 3.7 μM,\nrespectively.%END_SNIPPET% The general toxicity of 5'-noraristeromycin was studied in experiments on white mice upon\nsingle-dose intragastric administration; toxicometric parameters were determined, and the clinical and\npathomorphological presentation of acute intoxication was studied. LD of the substance was shown to be\n63.2 (52.7÷75.8) mg/kg; LD16, 44.7 mg/kg, and LD84, 89.4 mg/kg.",
                "score": 0.7358033061027527,
                "part_metadata": {
                    "page": 12,
                    "lang": "eng",
                    "section": 59,
                    "offset": 0,
                    "len": 221
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "This, in turn, results in increased m6A modifications on\nRNA, resulting in positive feedback regulation. This novel mechanism illustrates how metabolism mutually\nacts with epitranscriptomic modifications, underscoring the pervasive impact of IGF2BP3 in gene regulatory\nmechanisms governing a broad range of cancer-specific processes. %START_SNIPPET%DNMT3AR882H Is Not Required for Disease Maintenance in\nPrimary Human AML, but Is Associated With Increased\nLeukemia Stem Cell Frequency.%END_SNIPPET% Authors: Thomas Koehnke, Daiki Karigane, Eleanor Hilgart, Amy C Fan, Kensuke Kayamori, Masashi\nMiyauchi, Cailin T Collins, Fabian P Suchy, Athreya Rangavajhula, Yang Feng, Yusuke Nakauchi, Eduardo\nMartinez-Montes, Jonas Fowler, Kyle M Loh, Hiromitsu Nakauchi, Michael A Koldobskiy, Andrew P Feinberg,\nRavindra Majeti Published: 2024-10-29",
                "score": 0.7350626587867737,
                "part_metadata": {
                    "page": 19,
                    "lang": "eng",
                    "section": 90,
                    "offset": 0,
                    "len": 136
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Published: 2024-11-01 PMID: 39555457 (https://pubmed.ncbi.nlm.nih.gov/39555457/) %START_SNIPPET%Abstract: BACKGROUND: Childhood acute myeloid leukemia (cAML) is the second most common pediatric\nblood cancer, with high heterogeneity and poor prognosis.%END_SNIPPET% Recent studies have highlighted cuproptosis, a\nnewly discovered form of programmed cell death triggered by the accumulation of intracellular copper\nions, as a critical mechanism influencing cancer survival and resistance. Given its emerging role in cancer\nbiology, we investigated cuproptosis-related genes (CRGs) in cAML to explore their potential in prognostic\nprediction and therapeutic targeting.",
                "score": 0.7321380376815796,
                "part_metadata": {
                    "page": 10,
                    "lang": "eng",
                    "section": 49,
                    "offset": 0,
                    "len": 155
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "CONCLUSION: Heavily pretreated patients\nexperienced greater symptom burden and bother, but patients at earlier LOTs also had unmet needs. Interventions are needed to improve symptom management in MM regardless of LOT, but most pressingly\nfor heavily pretreated patients. %START_SNIPPET%Diagnosis and typing of leukemia using a single peripheral\nblood cell through deep learning.%END_SNIPPET% Authors: Geng Yan, Gao Mingyang, Shi Wei, Liang Hongping, Qin Liyuan, Liu Ailan, Kong Xiaomei, Zhao\nHuilan, Zhao Juanjuan, Qiang Yan Published: 2024-11-18",
                "score": 0.7278808951377869,
                "part_metadata": {
                    "page": 9,
                    "lang": "eng",
                    "section": 40,
                    "offset": 0,
                    "len": 92
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "The present study aimed to investigate whether acetylated derivatives of\ncordycepin altered its original antitumor properties and exerted cardioprotective effects by promoting\nangiogenesis and . METHODS: Cordycepin and its derivatives with single (DA), double (DAA), and triple\nacetyl groups (DAAA) were assessed. %START_SNIPPET%The cell viability of leukemia U937 cells, malignant hepatoma\nHuh-7 cells, and human umbilical vascular endothelial cells (HUVECs) treated with cordycepin, DA, DAA,\nand DAAA were determined.%END_SNIPPET% The expression of β-catenin in U937 cells, as well as the expression of p65,\np38 and other related signal regulators in HUVECs elicited by lipopolysaccharides (LPS) were also observed. Angiogenesis was determined by tube formation in HUVECs and Matrigel plug assay in mice.",
                "score": 0.7265292406082153,
                "part_metadata": {
                    "page": 20,
                    "lang": "eng",
                    "section": 99,
                    "offset": 439,
                    "len": 190
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "PMID: 39556650 (https://pubmed.ncbi.nlm.nih.gov/39556650/) Abstract: The study of circulating peptides in the blood offers significant opportunities for diagnosing,\nstratifying, and managing various diseases. %START_SNIPPET%With recent technological advances and the ongoing need to\nunderstand complex diseases such as acute leukemias (AL), peptidomic analysis of peripheral blood,\nespecially serum and plasma, has become increasingly important for studying human biology and\npathophysiology.%END_SNIPPET% Here, we provide insights and perspectives on technological developments and potential\nclinical applications using widely used peptidomic analysis methods. We discuss examples where\npeptidomics using serum or plasma has contributed to the understanding of AL.",
                "score": 0.7226380109786987,
                "part_metadata": {
                    "page": 4,
                    "lang": "eng",
                    "section": 19,
                    "offset": 150,
                    "len": 268
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "We found a core program of epigenetic\nlandscape disruption across all AML subtypes, with discordant methylation stochasticity and transcriptional\ndysregulation converging on functionally important leukemic signatures, suggesting a\ngenotype-independent role of stochastic disruption of the epigenetic landscape in mediating\nleukemogenesis. We further established a relationship between methylation entropy and gene expression\nvariability, connecting the disruption of the epigenetic landscape to transcription in AML. %START_SNIPPET%This approach\nidentified a convergent program of epigenetic dysregulation in leukemia, clarifying the contribution of\nspecific genetic mutations to stochastic disruption of the epigenetic and transcriptional landscapes of AML.%END_SNIPPET% Metabolic regulation of RNA methylation by the m6A-reader\nIGF2BP3. Authors: Gunjan Sharma, Martin Gutierrez, Anthony E Jones, Amit Kumar Jaiswal, Zachary T Neeb, Amy\nRios, Michelle L Thaxton, Tasha L Lin, Tiffany M Tran, Lyna E S Kabbani, Alexander J Ritter, Linsey Stiles,\nJohanna Ten Hoeve, Ajit S Divakaruni, Jeremy R Sanford, Dinesh S Rao",
                "score": 0.7219460606575012,
                "part_metadata": {
                    "page": 17,
                    "lang": "eng",
                    "section": 84,
                    "offset": 1205,
                    "len": 226
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Published: 2024-10-29 PMID: 39554147 (https://pubmed.ncbi.nlm.nih.gov/39554147/) %START_SNIPPET%Abstract: Disruption of the epigenetic landscape is of particular interest in acute myeloid leukemia (AML)\ndue to its relatively low mutational burden and frequent occurrence of mutations in epigenetic regulators.%END_SNIPPET% Here, we applied an information-theoretic analysis of methylation potential energy landscapes, capturing\nchanges in mean methylation level and methylation entropy, to comprehensively analyze DNA methylation\nstochasticity in subtypes of AML defined by mutually exclusive genetic mutations. We identified AML\nsubtypes with CEBPA double mutation and those with IDH mutations as distinctly high-entropy subtypes,\nmarked by methylation disruption over a convergent set of genes.",
                "score": 0.7187448740005493,
                "part_metadata": {
                    "page": 17,
                    "lang": "eng",
                    "section": 84,
                    "offset": 0,
                    "len": 213
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "There were no unplanned interventions in\npatients with low tumor burden. CONCLUSION: In patients with low and medium tumor burden CLL who\nstart venetoclax, the incidence of TLS is very low, and interventions are uncommonly needed. %START_SNIPPET%Clinical Peptidomics in Acute Leukemias: Current Advances\nand Future Perspectives.%END_SNIPPET% Authors: Danila Felix Coutinho, Túlio Resende Freitas, Ana Carolina Silva Batista, Mariana Torquato\nQuezado de Magalhães, Adriano de Paula Sabino Published: 2024-11-18",
                "score": 0.7185497879981995,
                "part_metadata": {
                    "page": 4,
                    "lang": "eng",
                    "section": 15,
                    "offset": 0,
                    "len": 82
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "It is trained on a self-built\nannotated dataset of 21,208 images from 237 patients, including five types of benign white blood\ncells(WBCs) and eight types of leukemic cells. The network is not only able to discriminate between benign\nand malignant cells, but also to typify leukemia using a single peripheral blood cell. %START_SNIPPET%The network effectively\ndifferentiated acute promyelocytic leukemia (APL) from other types of acute myeloid leukemia (non-APL),\nachieving a precision rate of 89.34%, a recall rate of 97.37%, and an F1 score of 93.18% for APL.%END_SNIPPET% In\ncontrast, for non-APL cases, the model achieved a precision rate of 92.86%, but a recall rate of 74.63% and\nan F1 score of 82.75%. In addition, the model discriminates acute lymphoblastic leukemia(ALL) with the Ph\nchromosome from those without.",
                "score": 0.7167314887046814,
                "part_metadata": {
                    "page": 9,
                    "lang": "eng",
                    "section": 44,
                    "offset": 1122,
                    "len": 225
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "CONCLUSION: In this study of older patients with AML considered fit\nand with evidence of residual disease after first induction, chemotherapy intensification improved survival. DAC intensification was better tolerated than FLAG-Ida. %START_SNIPPET%Evaluation of the Impact of Monitoring for Tumor Lysis\nDuring Venetoclax Ramp-Up in Chronic Lymphocytic\nLeukemia in Routine Clinical Practice.%END_SNIPPET% Authors: Nilanjan Ghosh, Ashley Matusz-Fisher, Rupali Bose, Danielle Boselli, Gray Magee, Tommy Chen,\nBei Hu, Tamara Moyo, Amy Soni, Steven Park, Edward Copelan, Belinda Avalos, James Symanowski, Derek\nRaghavan, Ryan Jacobs Published: 2024-11-18",
                "score": 0.7154874801635742,
                "part_metadata": {
                    "page": 3,
                    "lang": "lat",
                    "section": 10,
                    "offset": 0,
                    "len": 142
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Early intervention and multidisciplinary management are crucial for\nimproving treatment outcomes. Increased awareness and education about the various clinical\npresentations of MS lead to earlier diagnosis and timely treatment, thereby enhancing patients' survival\nand quality of life. %START_SNIPPET%Continued research is essential for optimizing therapeutic strategies and addressing the\nchallenges presented by this rare neoplasm.%END_SNIPPET% Resolution of Anterior Uveal Infiltration of Acute\nLymphoblastic Leukemia After Chimeric Antigen Receptor\nT-Cell Therapy. Authors: Jaskirat S Takhar, Ankur A Mehra, Shree K Kurup, Warren M Sobol, Rabail Aslam, Kwadwo A Oduro,\nJose J Echegaray",
                "score": 0.7153279781341553,
                "part_metadata": {
                    "page": 15,
                    "lang": "eng",
                    "section": 74,
                    "offset": 1382,
                    "len": 132
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Significant differences in immune cell composition were\nidentified between risk groups, particularly in T cells, B cells, monocytes, and dendritic cells. Drug\nsensitivity analysis revealed altered IC50 values for drugs like 5-fluorouracil and bortezomib. %START_SNIPPET%Knockdown of\nCNN3 in leukemia cell lines led to reduced cell proliferation.%END_SNIPPET% CONCLUSION: Our CRGs-based prognostic\nmodel shows potential for guiding personalized treatment strategies in cAML. The differences in immune\ncell infiltration between risk groups suggest that immune modulation is key in cAML progression.",
                "score": 0.7151247262954712,
                "part_metadata": {
                    "page": 10,
                    "lang": "eng",
                    "section": 49,
                    "offset": 1617,
                    "len": 75
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "PMID: 39553934 (https://pubmed.ncbi.nlm.nih.gov/39553934/) Abstract: Genetic mutations are being thoroughly mapped in human cancers, yet a fundamental question\nin cancer biology is whether such mutations are functionally required for cancer initiation, maintenance of\nestablished cancer, or both. %START_SNIPPET%Here, we study this question in the context of human acute myeloid leukemia\n(AML), where DNMT3AR882 missense mutations often arise early, in pre-leukemic clonal hematopoiesis,\nand corrupt the DNA methylation landscape to initiate leukemia.%END_SNIPPET% We developed CRISPR-based methods to\ndirectly correct DNMT3AR882 mutations in leukemic cells obtained from patients. Surprisingly,\nDNMT3AR882 mutations were largely dispensable for disease maintenance.",
                "score": 0.7143003344535828,
                "part_metadata": {
                    "page": 19,
                    "lang": "eng",
                    "section": 94,
                    "offset": 238,
                    "len": 239
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Yet, how its function as\na reader overlaps with its critical oncogenic function in leukemia remains an open question. Here, we\nreport the novel finding that the reader IGF2BP3 reprograms cellular metabolism, resulting in an altered\nability of the \"writers\" to modify the epitranscriptome. %START_SNIPPET%In leukemia cells, IGF2BP3 supports increased\nglycolytic flux and one-carbon metabolism, leading to increased production of S-adenosyl methionine\n(SAM), a key substrate for methylation reactions within the cell.%END_SNIPPET% IGF2BP3 directly regulates the translation\nof MAT2B, the regulatory subunit of the methionine-adenosyltransferase complex, which is the final\nenzyme in a pathway leading to SAM production. This, in turn, results in increased m6A modifications on\nRNA, resulting in positive feedback regulation.",
                "score": 0.7124682664871216,
                "part_metadata": {
                    "page": 18,
                    "lang": "eng",
                    "section": 89,
                    "offset": 686,
                    "len": 211
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Published: 2024-11-18 PMID: 39556786 (https://pubmed.ncbi.nlm.nih.gov/39556786/) %START_SNIPPET%Abstract: PURPOSE: Venetoclax is the standard of care for chronic lymphocytic leukemia (CLL)/small\nlymphocytic lymphoma (SLL) but requires intensive monitoring for optimal safety.%END_SNIPPET% Clinical relevance of\nintensive monitoring in practice is unknown, especially for patients with low or intermediate risk for tumor\nlysis syndrome (TLS). PATIENTS AND METHODS: A retrospective review was conducted to determine clinical\nsignificance of monitoring for TLS during standard ramp-up for patients with CLL/SLL.",
                "score": 0.712307333946228,
                "part_metadata": {
                    "page": 1,
                    "lang": "eng",
                    "section": 4,
                    "offset": 0,
                    "len": 179
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Analysis of protein\ninteractions suggested that arginine methylation of p30 C/EBPα differentially determines interactions with\nSWI/SNF and MLL complexes. Pharmacological targeting of p30 C/EBPα arginine methylation may have\nclinical relevance in myeloproliferative and inflammatory diseases, in neutropenia, and in leukemic stem\ncells. %START_SNIPPET%5'-Noraristeromycin Repurposing: Well-known\nS-Adenosyl-L-homocysteine Hydrolase Inhibitor As a\nPotential Drug Against Leukemia.%END_SNIPPET% Authors: O N Novikova, E S Matyugina, A V Gorshenin, Yu I Velikorodnaya, M D Krengauz, V O Vedernikova,\nP V Spirin, V S Prassolov, S N Kochetkov, A L Khandazhinskaya Published: 2024--",
                "score": 0.7082754373550415,
                "part_metadata": {
                    "page": 12,
                    "lang": "eng",
                    "section": 55,
                    "offset": 0,
                    "len": 127
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Early deaths and other adverse events were more frequent with FLAG-Ida (9% day 60 deaths\n4% after DA or DAC; = .032). Of patients entering random assignment, 131 had MRD unknown status. %START_SNIPPET%In\nthis subgroup of patients lacking evidence of residual leukemia by flow cytometry, there was no detectable\nsurvival advantage from intensification.%END_SNIPPET% A planned sensitivity analysis excluding these patients\ndemonstrated a survival benefit for both DAC (HR, 0.66 [95% CI, 0.46 to 0.93]; = .018) and FLAG-Ida (HR,\n0.72 [95% CI, 0.53 to 0.98]; = .035); OS at 3 years was 30%, 46%, and 46% for DA, DAC, and FLAG-Ida,\nrespectively. There was a concordant reduction in relapse (DAC DA: HR, 0.66 [95% CI, 0.45 to 0.98]; =\n.039; FLAG-Ida DA: HR, 0.70 [95% CI, 0.49 to 0.99]; = .042).",
                "score": 0.705725371837616,
                "part_metadata": {
                    "page": 2,
                    "lang": "eng",
                    "section": 9,
                    "offset": 1095,
                    "len": 150
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "The network effectively\ndifferentiated acute promyelocytic leukemia (APL) from other types of acute myeloid leukemia (non-APL),\nachieving a precision rate of 89.34%, a recall rate of 97.37%, and an F1 score of 93.18% for APL. In\ncontrast, for non-APL cases, the model achieved a precision rate of 92.86%, but a recall rate of 74.63% and\nan F1 score of 82.75%. %START_SNIPPET%In addition, the model discriminates acute lymphoblastic leukemia(ALL) with the Ph\nchromosome from those without.%END_SNIPPET% This approach could improve patient compliance and enable faster and\nmore accurate typing of leukemias for early diagnosis and treatment to improve survival. Development of a prognostic model incorporating a\ncuproptosis-related signature and CNN3 as a predictor in\nchildhood acute myelocytic leukemia.",
                "score": 0.7031832337379456,
                "part_metadata": {
                    "page": 9,
                    "lang": "eng",
                    "section": 44,
                    "offset": 1482,
                    "len": 113
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "These patients and those with\npersistent PV symptoms may benefit from cytoreductive therapy with hydroxyurea or interferon to lower\nthrombosis risk and decrease symptoms. Ruxolitinib is a Janus kinase inhibitor that can alleviate pruritus\nand decrease splenomegaly in patients who are intolerant of or resistant to hydroxyurea. %START_SNIPPET%About 12.7% of\npatients with PV develop myelofibrosis and 6.8% develop acute myeloid leukemia.%END_SNIPPET% CONCLUSIONS AND\nRELEVANCE: PV is a myeloproliferative neoplasm characterized by erythrocytosis and is almost universally\nassociated with a JAK2 gene variant. PV is associated with an increased risk of arterial and venous\nthrombosis, hemorrhage, myelofibrosis, and acute myeloid leukemia.",
                "score": 0.7021854519844055,
                "part_metadata": {
                    "page": 5,
                    "lang": "eng",
                    "section": 24,
                    "offset": 1804,
                    "len": 94
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Published: 2024-11-18 PMID: 39556332 (https://pubmed.ncbi.nlm.nih.gov/39556332/) %START_SNIPPET%Abstract: OBJECTIVE: We aim to evaluate the efficacy and safety of blinatumomab for the treatment of\npost-transplant relapse patients with acute lymphoblastic leukemia (ALL).%END_SNIPPET% METHODS: The search was\nconducted using several databases including the PubMed, Cochrane Library, Embase, Chinese National\nKnowledge Infrastructure (CNKI) and Wanfang Data Knowledge Service Platform to collect clinical studies\nrelated to blinatumomab. The primary outcome measures were complete remission (CR), 1-year overall\nsurvival (OS), 2-year OS, median OS and adverse events (AEs).",
                "score": 0.7005735635757446,
                "part_metadata": {
                    "page": 6,
                    "lang": "eng",
                    "section": 29,
                    "offset": 0,
                    "len": 174
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "In this study, we apply a segmentation-based enhanced residual\nnetwork that uses progressive multigranularity training with jigsaw patches. It is trained on a self-built\nannotated dataset of 21,208 images from 237 patients, including five types of benign white blood\ncells(WBCs) and eight types of leukemic cells. %START_SNIPPET%The network is not only able to discriminate between benign\nand malignant cells, but also to typify leukemia using a single peripheral blood cell.%END_SNIPPET% The network effectively\ndifferentiated acute promyelocytic leukemia (APL) from other types of acute myeloid leukemia (non-APL),\nachieving a precision rate of 89.34%, a recall rate of 97.37%, and an F1 score of 93.18% for APL. In\ncontrast, for non-APL cases, the model achieved a precision rate of 92.86%, but a recall rate of 74.63% and\nan F1 score of 82.75%.",
                "score": 0.7001729607582092,
                "part_metadata": {
                    "page": 9,
                    "lang": "eng",
                    "section": 44,
                    "offset": 975,
                    "len": 146
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "About 12.7% of\npatients with PV develop myelofibrosis and 6.8% develop acute myeloid leukemia. CONCLUSIONS AND\nRELEVANCE: PV is a myeloproliferative neoplasm characterized by erythrocytosis and is almost universally\nassociated with a JAK2 gene variant. %START_SNIPPET%PV is associated with an increased risk of arterial and venous\nthrombosis, hemorrhage, myelofibrosis, and acute myeloid leukemia.%END_SNIPPET% To decrease the risk of thrombosis,\nall patients with PV should be treated with aspirin and therapeutic phlebotomy to maintain a hematocrit of\nless than 45%. Cytoreductive therapies, such as hydroxyurea or interferon, are recommended for patients\nat high risk of thrombosis.",
                "score": 0.6998373866081238,
                "part_metadata": {
                    "page": 5,
                    "lang": "eng",
                    "section": 24,
                    "offset": 2057,
                    "len": 129
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            },
            {
                "text": "Abstract: The transcription factor CCAAT enhancer binding protein alpha (C/EBPα) is a master regulator of\nmyelopoiesis. encodes a long (p42) and a truncated (p30) protein isoform from a single mRNA. %START_SNIPPET%Mutations\nthat abnormally enhance expression of p30 are associated with acute myelogenous leukemia (AML).%END_SNIPPET% We\nshow by mutational analysis that three highly conserved arginine residues in the p30 C/EBPα N-terminus,\npreviously found to be methylated, are involved in myeloid lineage commitment, progenitor proliferation,\nand differentiation. The conservative amino acid substitution with lysine that retains the amino acid side\nchain charge enhanced progenitor proliferation, while a non-conservative substitution with uncharged side\nchains (alanine, leucine) impaired proliferation and enhanced granulopoiesis.",
                "score": 0.6981238722801208,
                "part_metadata": {
                    "page": 11,
                    "lang": "eng",
                    "section": 54,
                    "offset": 199,
                    "len": 105
                },
                "document_metadata": {
                    "CreationDate": 1731973908,
                    "Keywords": "",
                    "Producer": "ReportLab PDF Library - www.reportlab.com",
                    "Author": "(anonymous)",
                    "Title": "(anonymous)",
                    "Creator": "(unspecified)",
                    "ModDate": 1731973908,
                    "Trapped": "/False",
                    "Subject": "(unspecified)",
                    "title": "(anonymous)"
                },
                "document_id": "leukemia-output.pdf"
            }
        ],
        "rewritten_queries": []
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "The lates"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "t researc"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "h on leuk"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "emia inc"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "lud"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "es s"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "tudies"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " on its "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "heterogenei"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ty, di"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "a"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "gnos"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "tic tests,"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " and treatm"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "n"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "t "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "approac"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "hes[1]. R"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ecent find"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ings"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " h"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ig"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "hlig"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ht "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "cu"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "proptosis"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " as a crit"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ical mechani"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "sm infl"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "uencing c"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "a"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ncer surviv"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "al,"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " especiall"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "y in c"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "hil"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "dh"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ood"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " acute my"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "el"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "o"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "id "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "le"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "u"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ke"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "mia (cAML)[4]"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "."
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " Add"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "itio"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "nally,"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " the cyt"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "oto"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "x"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "i"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "c "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "eff"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ec"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ts of"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " 5"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "'-No"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "rar"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "isteromyc"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "in on "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "leuke"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "mia c"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ells hav"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " been st"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "udied, sho"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "wing pro"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "m"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "i"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "si"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ng res"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ults[2]. No"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "vel mechan"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "is"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ms"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "in"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "v"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "olvi"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ng I"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "GF2BP3 "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "and"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " its "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "impact on g"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ene regulat"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ory"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " mechanis"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ms in"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " leuk"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "emia "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "have also"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "b"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ee"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "n explor"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "d[3]. Overall,"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " und"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "erstanding th"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e c"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "omplexiti"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "s of leuke"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "mia,"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " exploring"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " new t"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "reatm"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "nt m"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "odalities, and"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " investiga"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ting p"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ote"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "nt"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ial prog"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "nost"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "ic m"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "arkers"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " ar"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "e key "
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "are"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "as o"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "f focus"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": " in the l"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "atest leu"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "k"
    },
    {
        "type": "generation_chunk",
        "generation_chunk": "emia research."
    },
    {
        "type": "generation_end"
    },
    {
        "type": "factual_consistency_score",
        "factual_consistency_score": 0.42138672
    }
]